ÂÜÀòÂÒÂ×

Katherine Stueland is an accomplished healthcare executive with extensive experience in transforming patient care through innovative business strategies. As the Chief Executive Officer at GeneDx since June 2021, Katherine has continued a distinguished career that includes serving as Chief Commercial Officer at Invitae from November 2013 to June 2021, where oversight of the commercial organization led to remarkable test volume and revenue growth. Prior roles include Vice President at Dendreon Corporation and Director at WCG, where Katherine provided strategic counsel across media, investor relations, and public communications. Katherine's career highlights also encompass roles at TAP Pharmaceutical Products Inc., Prescott Medical Communications, and Weber Shandwick, contributing to various high-stakes initiatives in healthcare communications. Katherine holds a Bachelor’s degree in science and English literature from Miami University, earned in 1997.